Mason Freeman
Professor of Medicine
United States
56 investmentsMason Freeman is a Professor of Medicine based in United States. Mason Freeman has backed 56 companies, including Precision NanoSystem, Vor Biopharma and Aprea. Investment focus areas include Health Care, Hospitals and Genetics.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (56)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Precision NanoSystem | — | — | — | — |
| 2 | Vor Biopharma | — | — | — | — |
| 3 | Aprea | — | — | — | — |
| 4 | Arvinas | — | — | — | — |
| 5 | GenePeeks | — | — | — | — |
| 6 | RareCyte | — | — | — | — |
| 7 | Portal Instruments | — | — | — | — |
| 8 | Entrada Therapeutics | — | — | — | — |
| 9 | Ceterix Orthopaedics | — | — | — | — |
| 10 | Audentes Therapeutics | — | — | — | — |
| 11 | CinCor Pharma | — | — | — | — |
| 12 | Homology Medicines | — | — | — | — |
Showing 1–12 of 56
Page 1 of 5
Access Full Contact Information
Get Mason Freeman's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.